ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1165408
Boston, MA
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$195,693,737
+$83,170,123 QoQ
Shares Held
393,964
+56.3% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#74
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. VRTX ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,693,737 | 393,964 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $112,523,614 | 251,990 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $123,528,812 | 272,474 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $188,964,341 | 482,495 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $79,331,078 | 178,192 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $237,400,354 | 489,667 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $84,260,545 | 209,239 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $161,082,783 | 346,355 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $157,096,663 | 335,161 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $146,410,510 | 350,256 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $122,144,309 | 300,190 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $104,323,390 | 300,004 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $107,696,073 | 306,033 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $106,616,537 | 338,390 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $51,948,634 | 179,890 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $97,622,175 | 337,163 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $161,192,333 | 572,030 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $207,024,891 | 793,290 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $48,507,444 | 220,890 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,554,604 | 173,960 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $68,340,472 | 338,940 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $190,766,448 | 887,740 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $161,216,967 | 682,140 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $79,184,198 | 290,990 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $116,022,972 | 399,652 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $216,761,028 | 910,952 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||